Malaria Transmission and Immunity in Highland Kenya

Sponsor
National Institute of Allergy and Infectious Diseases (NIAID) (NIH)
Overall Status
Completed
CT.gov ID
NCT00393757
Collaborator
(none)
20,610
1
52
396.3

Study Details

Study Description

Brief Summary

The purpose of this study is to see why malaria epidemics occur in highland areas in Kenya. A better understanding of factors contributing to malaria may be necessary for malaria vaccine planning. These factors include interactions between age, where malaria is passed from mosquitoes to people, immune system (how the body fights infection) responses and other factors that contribute to malaria in epidemic-prone areas. About 6400 people from the villages of Kapsisiywa and Kipsamoite will participate. Study procedures will include in home surveys, which will involve a census and an interview by researchers. Blood samples and smears will be collected from some volunteers in both communities to understand how the body protects itself from malaria and to check for malaria parasites. Twice each month, random houses will be selected from 3 places in the village to measure the number of mosquitoes in the home. Participants may be involved in the study for up to 4 years.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    The purpose of this study is to see why malaria epidemics occur in highland areas in Kenya. A better understanding of factors contributing to malaria may be necessary for malaria vaccine planning. These factors include interactions between age, where malaria is passed from mosquitoes to people, immune system (how the body fights infection) responses and other factors that contribute to malaria in epidemic-prone areas. About 6400 people from the villages of Kapsisiywa and Kipsamoite will participate. Study procedures will include in home surveys, which will involve a census and an interview by researchers. Blood samples and smears will be collected from some volunteers in both communities to understand how the body protects itself from malaria and to check for malaria parasites. Twice each month, random houses will be selected from 3 places in the village to measure the number of mosquitoes in the home. Participants may be involved in the study for up to 4 years.

    Study Design

    Study Type:
    Observational
    Time Perspective:
    Prospective
    Official Title:
    Malaria Transmission and Immunity in Highland Kenya
    Study Start Date :
    Oct 1, 2006
    Actual Primary Completion Date :
    Jan 31, 2011
    Actual Study Completion Date :
    Jan 31, 2011

    Outcome Measures

    Primary Outcome Measures

      Eligibility Criteria

      Criteria

      Ages Eligible for Study:
      N/A to 99 Years
      Sexes Eligible for Study:
      All
      Accepts Healthy Volunteers:
      Yes
      Inclusion Criteria:

      Active surveillance of clinical malaria -Individuals of any age who live in the area (Kipsamoite or Kapsisiywa) for more than 6 months of the year, or, if they are new to the area, who plan to live in the area for more than 6 months of the year (permanent residents).

      Passive surveillance of clinical malaria

      -Any individual living within the boundaries of the 2 study areas (Kipsamoite and Kapsisiywa)

      Exclusion Criteria:

      Active surveillance of clinical malaria

      • Declining to participate in the study

      • Will be gone from site more than 1 week per month

      • Not available for weekly symptom check or bimonthly blood sample collection

      Passive surveillance of clinical malaria

      • Declining to participate in the study

      • Participation in active surveillance study

      Contacts and Locations

      Locations

      Site City State Country Postal Code
      1 Kenya Medical Research Institute Kisumu Kenya 40100

      Sponsors and Collaborators

      • National Institute of Allergy and Infectious Diseases (NIAID)

      Investigators

      None specified.

      Study Documents (Full-Text)

      None provided.

      More Information

      Publications

      None provided.
      Responsible Party:
      , ,
      ClinicalTrials.gov Identifier:
      NCT00393757
      Other Study ID Numbers:
      • 05-0124
      • NCT00776061
      First Posted:
      Oct 29, 2006
      Last Update Posted:
      Feb 1, 2019
      Last Verified:
      Oct 1, 2007
      Keywords provided by , ,
      Additional relevant MeSH terms:

      Study Results

      No Results Posted as of Feb 1, 2019